$17.44
0.352.05%
At Close: -
$17.44
00.00%
After Hours: 4:45 PM EDT
15 minutes delayed
Cullinan Therapeutics
CGEMNASDAQ
Cullinan Therapeutics (CGEM) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCullinan Therapeutics (NASDAQ:CGEM) Stock Quotes, Forecast and News Summary
Cullinan Therapeutics Stock (NASDAQ: CGEM) stock price, news, charts, stock research, profile.
| Open | $17.42 |
| Close | $17.44 |
| Volume / Avg. | 3.44M / 911.38K |
| Day Range | 17.00 - 17.71 |
| 52 Wk Range | 7.64 - 30.19 |
| Market Cap | $1.01B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 35 |
| Short Interest | 9.11% |
| Days to Cover | 6.38 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cullinan Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-s...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cullinan Therapeutics (CGEM) stock?
You can purchase shares of Cullinan Therapeutics (NASDAQ:CGEM) through any online brokerage.
Who are Cullinan Therapeutics (CGEM) competitors?
Other companies in Cullinan Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT) and Cogent Biosciences (NASDAQ:COGT).
What is the target price for Cullinan Therapeutics (CGEM) stock?
There is no analysis for Cullinan Therapeutics.
What is the forecast for Cullinan Therapeutics (CGEM) stock?
Cullinan Therapeutics has a consensus price target of $22.67.
Current stock price for Cullinan Therapeutics (CGEM)?
The stock price for Cullinan Therapeutics (NASDAQ: CGEM) is $17.44 last updated June 28, 2024 at 4:45 PM EDT.
Does Cullinan Therapeutics (CGEM) pay a dividend?
There are no upcoming dividends for Cullinan Therapeutics.
When is Cullinan Therapeutics (NASDAQ:CGEM) reporting earnings?
Cullinan Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Cullinan Therapeutics (CGEM) going to split?
There is no upcoming split for Cullinan Therapeutics.
What sector and industry does Cullinan Therapeutics (CGEM) operate in?
Cullinan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.